发明授权
- 专利标题： Use of Lck inhibitors for treatment of immunologic diseases
- 专利标题（中）： 使用Lck抑制剂治疗免疫疾病
-
申请号： US12334323申请日： 2008-12-12
-
公开(公告)号： US07989474B2公开(公告)日： 2011-08-02
- 发明人: Gerald Juergen Roth , Armin Heckel , Rainer Walter , Frank Hilberg , Rudolf Hauptmann , Martin Fredrich Stefanic , Florian Colbatzky , Steffan Ernest
- 申请人： Gerald Juergen Roth , Armin Heckel , Rainer Walter , Frank Hilberg , Rudolf Hauptmann , Martin Fredrich Stefanic , Florian Colbatzky , Steffan Ernest
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人： Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Alan R. Stempel
- 优先权： DE10237423 20020816
- 主分类号： A61K31/445
- IPC分类号： A61K31/445
摘要：
The invention relates to a method of treating immunologic diseases or pathological conditions involving an immunologic component using certain Lck inhibitors already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more other drugs selected from NSAIDs, steroids, DMARDs, immunsuppressives, biologic response modifiers and antinfectives, pharmaceutical compositions comprising said Lck inhibitors together with said other drugs, and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.
公开/授权文献
信息查询
IPC分类:
